|
SGMS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.8359999999793E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.98459999999945E-05 |
| Normal-vs-Stage2 |
6.475000E-01 |
| Normal-vs-Stage3 |
2.20839999999223E-05 |
| Normal-vs-Stage4 |
3.287900E-02 |
| Stage1-vs-Stage2 |
1.896230E-01 |
| Stage1-vs-Stage3 |
2.877600E-01 |
| Stage1-vs-Stage4 |
7.780000E-01 |
| Stage2-vs-Stage3 |
6.614000E-02 |
| Stage2-vs-Stage4 |
3.402600E-01 |
| Stage3-vs-Stage4 |
2.877200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.96160000026846E-07 |
| Normal-vs-AfricanAmerican |
2.062100E-02 |
| Normal-vs-Asian |
1.452990E-01 |
| Caucasian-vs-AfricanAmerican |
5.717200E-01 |
| Caucasian-vs-Asian |
3.163800E-02 |
| AfricanAmerican-vs-Asian |
1.188980E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.884300E-02 |
| Normal-vs-Female |
6.76059999982215E-07 |
| Male-vs-Female |
1.196030E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.243400E-04 |
| Normal-vs-Age(41-60Yrs) |
3.576200E-04 |
| Normal-vs-Age(61-80Yrs) |
4.407900E-02 |
| Normal-vs-Age(81-100Yrs) |
3.104300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.490600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.217000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.271190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.567000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.541050E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.842790E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.457690E-03 |
| Classical-VS-Follicular |
1.62436730732907E-12 |
| Classical-VS-Other |
2.805800E-01 |
| Classical-VS-Normal |
2.68040001305536E-09 |
| Tall-VS-Follicular |
2.08322248340664E-12 |
| Tall-VS-Other |
3.777900E-03 |
| Tall-VS-Normal |
7.97879995406703E-09 |
| Follicular-VS-Other |
2.870000E-02 |
| Follicular-VS-Normal |
4.17320000000165E-05 |
| Other-VS-Normal |
5.299800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.333500E-02 |
| Normal-vs-N1 |
1.617370E-03 |
| N0-vs-N1 |
1.183960E-01 |
|
|
